학술논문
Is rapid acute coronary syndrome evaluation with high‐sensitivity cardiac troponin less costly? An economic evaluation
Document Type
article
Author
Shooshan Danagoulian; Joseph Miller; Bernard Cook; Satheesh Gunaga; Raef Fadel; Chaun Gandolfo; Nicholas L. Mills; Shalini Modi; Simon A. Mahler; Phillip D. Levy; Sachin Parikh; Seth Krupp; Khaled Abdul‐Nour; Howard Klausner; Steven Rockoff; Ryan Gindi; Aaron Lewandowski; Michael Hudson; Giuseppe Perrotta; Bryan Zweig; David Lanfear; Henry Kim; Elizabeth Shaheen; Gale Darnell; Hashem Nassereddine; Kegham Hawatian; Amy Tang; Catriona Keerie; James McCord
Source
Journal of the American College of Emergency Physicians Open, Vol 5, Iss 2, Pp n/a-n/a (2024)
Subject
Language
English
ISSN
2688-1152
Abstract
Abstract Objective Protocols to evaluate for myocardial infarction (MI) using high‐sensitivity cardiac troponin (hs‐cTn) have the potential to drive costs upward due to the added sensitivity. We performed an economic evaluation of an accelerated protocol (AP) to evaluate for MI using hs‐cTn to identify changes in costs of treatment and length of stay compared with conventional testing. Methods We performed a planned secondary economic analysis of a large, cluster randomized trial across nine emergency departments (EDs) from July 2020 to April 2021. Patients were included if they were 18 years or older with clinical suspicion for MI. In the AP, patients could be discharged without further testing at 0 h if they had a hs‐cTnI